Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net income/(loss)	$ 3,687,965	$ 2,967,218
Adjustment to reconcile net income/(loss) to net cash provided by/(used in) operating activities
Change in derivative liabilities	(3,111,760)	(795,779)
Intangible asset impairment	79,634	0
Interest expense from derivative instruments	273,582	296,182
Employee stock compensation	295,709	568,522
Provision for doubtful accounts	41,782	130,346
Depreciation and amortization	736,358	358,150
Changes in operating assets and liabilities
Accounts receivable	1,275,538	(2,167,733)
Prepaid expenses	(87,081)	(101,216)
Other current assets	6,259	23,592
Other assets	(85,133)	4,607
Accounts payable and accrued expenses	(515,887)	462,972
Patent settlement liability	(112,500)	(858,702)
Deferred revenue	(1,265,397)	(22,277)
Net cash provided by/(used in) operating activities	1,219,069	865,882
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(849,344)	(242,384)
Purchase of Acuity software	(552,403)	0
Net cash (used in) investing activities	(1,401,747)	(242,384)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of notes payable	(345,000)	(915,000)
Repayments of notes payable, related parties	0	(105,000)
Proceeds/(repayments) from revolving line of credit	250,000	(50,000)
Proceeds from exercise of stock options	45,000	35,250
Proceeds from exercise of warrants	600,000	155,000
Principal repayment of capital lease obligation	(67,817)	0
Net cash provided by/(used in) financing activities	482,183	(879,750)
Effect of exchange rate changes on fixed and intangible assets	3,736	(19,797)
Effect of exchange rate changes on cash and cash equivalents	(39,268)	13,268
Net increase/(decrease) in cash and cash equivalents	263,973	(262,781)
Cash and cash equivalents at beginning of year	1,176,551	1,439,332
Cash and cash equivalents at end of year	1,440,524	1,176,551
Supplemental disclosures of cash flow information:
Income taxes	327,319	1,194
Interest	1,144,586	1,051,909
Non-cash transactions:
Notes payable issued in exchange for existing notes payable	0	350,000
Restricted stock issuance/(forfeiture)	94,147	(2,834)
Common stock issued for the purchase of Acuity software	500,000	0
Capital expenditures funded by capital lease borrowing	359,603	0
Reclassification of conversion feature liability associated with convertible debt	10,500	402,567
Reclassification of warrant feature liability associated with warrant exercise	9,248	0
Exercise of warrants as repayment of notes payable, related party	$ 400,000	$ 0